AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Schering acquires European distribution rights for Testogel hormone therapy.(Schering AG)(Brief Article)
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
German pharmaceutical company Schering AG has signed a distribution agreement with Besins International of France.
Under the terms of the agreement Schering will sell and distribute Besins' testosterone replacement therapy Testogel in most European countries.
Testogel is approved for the treatment of testosterone deficiency in men, a condition which can cause loss of libido and loss of bone density as well as depressive …
